Periodic Fever Market
- 2026 年市場規模
- USD 724.6 Mn
- 2033 年預估規模
- USD 1,006.07 Mn
- 年複合成長率 CAGR
- 4.8%
以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。
授權報價
| Single User Price | $4,500 USD |
| Enterprise License | $10,000 USD |
完整報告名稱與涵蓋範圍
Periodic Fever Market, By Disease Type (Familial Mediterranean Fever, TNF ReceptorAssociated Periodic Syndrome, Mevalonate Kinase Deficiency, Cryopyrin-Associated Periodic Syndromes, PFAPA Syndrome, and Systemic Autoinflammatory Periodic Fevers), By Treatment Type (Biologic Therapies, Corticosteroids, Colchicine Therapy, NSAIDs & Symptomatic Treatments, Immunosuppressants, and Emerging Targeted Therapies & Gene-based Treatments), By Route of Administration (Injectable, Oral, and Intravenous Infusion), By Diagnosis Type (Genetic Testing, Laboratory & Biomarker Testing, Clinical Diagnosis, and Imaging & Supportive Diagnostic Methods), By Patient Group (Pediatric Patients and Adult Patients), By End User (Hospitals, Specialty & Rheumatology Clinics, Ambulatory Surgical Centers, and Homecare Settings), By Distribution Channel (Online and Offline), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East and Africa)
報告摘要
According to Coherent Market Insights, the global periodic fever market is estimated to be valued at USD 724.6 Mn in 2026 and is expected to reach 1,006.07 Mn by 2033, exhibiting a compound annual growth rate (CAGR) of 4.8% from 2026 to 2033. The global periodic fever market encompasses a specialized segment of the rare disease therapeutics landscape, focusing on hereditary autoinflammatory syndromes characterized by recurrent episodes of fever and inflammation. These conditions, including Familial Mediterranean Fever (FMF), Tumor Necrosis Factor Receptor Associated Periodic Syndrome (TRAPS), and Cryopyrin-Associated Periodic Syndromes (CAPS), represent a group of genetically inherited disorders affecting thousands of patients worldwide.
The market has witnessed significant advancement in recent years, driven by enhanced diagnostic capabilities, improved understanding of disease pathophysiology, and the development of targeted therapeutic interventions. Pharmaceutical companies and biotechnology firms are increasingly investing in research and development activities to address the substantial unmet medical needs within this patient population.
The market encompasses various treatment modalities, including anti-inflammatory agents, biologics, and novel targeted therapies designed to prevent or reduce the frequency and severity of periodic fever episodes. With growing awareness among healthcare professionals and improved diagnostic techniques, the market is experiencing steady expansion as more patients receive accurate diagnoses and appropriate treatment interventions, ultimately improving quality of life outcomes for individuals suffering from these debilitating autoinflammatory conditions.
Market Dynamics
The global periodic fever market is primarily driven by several compelling factors that continue to shape its growth trajectory and market penetration. The increasing prevalence and recognition of hereditary autoinflammatory syndromes worldwide serves as a fundamental growth driver, as healthcare systems become more sophisticated in diagnosing these previously under-recognized conditions through advanced genetic testing and biomarker identification technologies. The development of targeted biologics and precision medicine approaches has revolutionized treatment paradigms, offering patients more effective therapeutic options with improved safety profiles compared to traditional anti-inflammatory treatments.
Government initiatives and regulatory support for orphan drug development, including expedited approval pathways and market exclusivity incentives, have encouraged pharmaceutical investments in this niche therapeutic area. However, the market faces significant restraints including the extremely high costs associated with biologic therapies, which create accessibility barriers for patients and healthcare systems, particularly in developing economies. Limited disease awareness among primary care physicians often leads to delayed diagnoses and prolonged patient suffering, while the small patient populations inherent to rare diseases present commercial challenges for pharmaceutical companies seeking return on investment.
The complexity of these genetic disorders and variability in clinical presentations create additional diagnostic and treatment challenges. Nevertheless, substantial opportunities exist through expanding global healthcare infrastructure, increasing healthcare expenditure in emerging markets, and growing pharmaceutical industry focus on rare disease portfolios. The potential for combination therapies, personalized treatment approaches based on genetic profiling, and the development of next-generation therapeutics with improved efficacy and reduced side effect profiles represent significant market expansion opportunities that could transform patient outcomes and market dynamics.
Key Features of the Study
• This report provides in-depth analysis of the global Periodic Fever market, and provides market size (USD Mn) and compound annual growth rate (CAGR%) for the forecast period (2026–2033), considering 2025 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global periodic fever market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Novartis, Swedish Orphan Biovitrum Sobi, Regeneron Pharmaceuticals, Takeda Pharmaceutical Company, Hikma Pharmaceuticals, Amgen, Pfizer, AbbVie, Janssen Biotech Johnson and Johnson, Roche, Sanofi, UCB, Bristol Myers Squibb, Teva Pharmaceutical Industries, and Dr Reddys Laboratories
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global periodic fever market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global periodic fever market
Market Segmentation
• Disease Type Insights (Revenue, USD Mn, 2021 - 2033)
o Familial Mediterranean Fever
o TNF Receptor–Associated Periodic Syndrome
o Mevalonate Kinase Deficiency
o Cryopyrin-Associated Periodic Syndromes
o PFAPA Syndrome
o Systemic Autoinflammatory Periodic Fevers
• Treatment Type Insights (Revenue, USD Mn, 2021 - 2033)
o Biologic Therapies
o Corticosteroids
o Colchicine Therapy
o NSAIDs & Symptomatic Treatments
o Immunosuppressants
o Emerging Targeted Therapies & Gene-based Treatments
• Route of Administration Insights (Revenue, USD Mn, 2021 - 2033)
o Injectable
o Oral
o Intravenous Infusion
• Diagnosis Type Insights (Revenue, USD Mn, 2021 - 2033)
o Genetic Testing
o Laboratory & Biomarker Testing
o Clinical Diagnosis
o Imaging & Supportive Diagnostic Methods
• Patient Group Insights (Revenue, USD Mn, 2021 - 2033)
o Pediatric Patients
o Adult Patients
• End User Insights (Revenue, USD Mn, 2021 - 2033)
o Hospitals
o Specialty & Rheumatology Clinics
o Ambulatory Surgical Centers
o Homecare Settings
• Distribution Channel Insights (Revenue, USD Mn, 2021 - 2033)
o Online
o Offline
• Regional Insights (Revenue, USD Mn, 2021 - 2033)
o North America
U.S.
Canada
o Latin America
Brazil
Argentina
Mexico
Rest of Latin America
o Europe
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
o Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
o Middle East
GCC Countries
Israel
Rest of Middle East
o Africa
South Africa
North Africa
Central Africa
• Key Players Insights
o Novartis
o Swedish Orphan Biovitrum Sobi
o Regeneron Pharmaceuticals
o Takeda Pharmaceutical Company
o Hikma Pharmaceuticals
o Amgen
o Pfizer
o AbbVie
o Janssen Biotech Johnson and Johnson
o Roche
o Sanofi
o UCB
o Bristol Myers Squibb
o Teva Pharmaceutical Industries
o Dr Reddys Laboratories
目錄 Table of Contents
Table of Contents
1. Research Objectives and Assumptions
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
Market Definition and Scope
o Executive Summary
Global Periodic Fever Market, By Disease Type
Global Periodic Fever Market, By Treatment Type
Global Periodic Fever Market, By Route of Administration
Global Periodic Fever Market, By Diagnosis Type
Global Periodic Fever Market, By Patient Group
Global Periodic Fever Market, By End User
Global Periodic Fever Market, By Distribution Channel
Global Periodic Fever Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
o Impact Analysis
o Key Highlights
o Regulatory Scenario
o Product Launches/Approvals
o PEST Analysis
o PORTER’s Analysis
o Market Opportunities
o Regulatory Scenario
o Key Developments
o Industry Trends
4. Global Periodic Fever Market, By Disease Type, 2021-2033, (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o Familial Mediterranean Fever
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o TNF Receptor–Associated Periodic Syndrome
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Mevalonate Kinase Deficiency
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Cryopyrin-Associated Periodic Syndromes
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o PFAPA Syndrome
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Systemic Autoinflammatory Periodic Fevers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
5. Global Periodic Fever Market, By Treatment Type, 2021-2033, (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o Biologic Therapies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Corticosteroids
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Colchicine Therapy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o NSAIDs & Symptomatic Treatments
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Immunosuppressants
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Emerging Targeted Therapies & Gene-based Treatments
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
6. Global Periodic Fever Market, By Route of Administration, 2021-2033, (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o Injectable
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Oral
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Intravenous Infusion
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
7. Global Periodic Fever Market, By Diagnosis Type, 2021-2033, (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o Genetic Testing
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Laboratory & Biomarker Testing
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Clinical Diagnosis
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Imaging & Supportive Diagnostic Methods
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
8. Global Periodic Fever Market, By Patient Group, 2021-2033, (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o Pediatric Patients
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Adult Patients
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
9. Global Periodic Fever Market, By End User, 2021-2033, (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o Hospitals
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Specialty & Rheumatology Clinics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Ambulatory Surgical Centers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Homecare Settings
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
10. Global Periodic Fever Market, By Distribution Channel, 2021-2033, (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o Online
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Offline
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
11. Global Periodic Fever Market, By Region, 2021 - 2033, Value (USD Mn)
o Introduction
Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Mn)
Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)
Regional Trends
o North America
Introduction
Market Size and Forecast, By Disease Type, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Treatment Type, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Diagnosis Type, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Patient Group, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
o U.S.
o Canada
o Latin America
Introduction
Market Size and Forecast, By Disease Type, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Treatment Type, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Diagnosis Type, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Patient Group, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
o Brazil
o Argentina
o Mexico
o Rest of Latin America
o Europe
Introduction
Market Size and Forecast, By Disease Type, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Treatment Type, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Diagnosis Type, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Patient Group, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
o Germany
o U.K.
o Spain
o France
o Italy
o Russia
o Rest of Europe
o Asia Pacific
Introduction
Market Size and Forecast, By Disease Type, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Treatment Type, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Diagnosis Type, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Patient Group, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
o China
o India
o Japan
o Australia
o South Korea
o ASEAN
o Rest of Asia Pacific
o Middle East
Introduction
Market Size and Forecast, By Disease Type, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Treatment Type, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Diagnosis Type, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Patient Group, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
o GCC Countries
o Israel
o Rest of Middle East
o Africa
Introduction
Market Size and Forecast, By Disease Type, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Treatment Type, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Diagnosis Type, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Patient Group, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn)
o South Africa
o North Africa
o Central Africa
12. Competitive Landscape
o Novartis
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Swedish Orphan Biovitrum Sobi
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Regeneron Pharmaceuticals
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Takeda Pharmaceutical Company
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Hikma Pharmaceuticals
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Amgen
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Pfizer
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o AbbVie
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Janssen Biotech Johnson and Johnson
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Roche
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Sanofi
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o UCB
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Bristol Myers Squibb
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Teva Pharmaceutical Industries
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Dr Reddys Laboratories
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
13. Analyst Recommendations
o Wheel of Fortune
o Analyst View
o Coherent Opportunity Map
14. References and Research Methodology
o References
o Research Methodology
o About us
*Browse 32 market data tables and 28 figures on 'Periodic Fever Market' - Global forecast to 2033
提及公司
同分類最新報告（醫療與生命科學）
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們